Second Nitrosamine Implementation Oversight Group (NIOG) - meeting with pharmaceutical industry

• Date:
  Wednesday, 8 December 2021, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.

The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.

This is the second meeting of the NIOG with industry stakeholders. The aim is to provide an update on progress of NIOG workplan and discuss priorities for 2022.

Registration

Registration by invitation only.

Documents

Agenda - Nitrosamine Implementation Oversight Group (NIOG) - second meeting with pharmaceutical industry

Adopted Reference Number: EMA/535229/2021

Highlights from the second meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry

Reference Number: EMA/711797/2021

Presentation - Nitrosamine Implementation Oversight Group (NIOG) - second meeting with pharmaceutical industry

Presentation - Industry stakeholder supporting presentation